中国大动脉炎相关高血压诊治多学科专家共识

2021-03-30 大动脉炎相关高血压诊治多学科共识中国专家组 复旦学报

目前尚无TARH诊治的指南或共识,为此,我们联合国内风湿免疫科、心内科、肾内科、血管外科、神经内科等相关学科专家在国内首次制定了中国TARH诊治多学科专家共识,旨在为相关临床科室提供治疗上的指导与建议

中文标题:

中国大动脉炎相关高血压诊治多学科专家共识

发布日期:

2021-03-30

简要介绍:

大动脉炎(Takayasu’s arteritis,TA)是好发于亚洲国家年轻女性的原发性血管炎症性疾病,大动脉炎相关高血压(Takayasu’s arteritis-related hypertension,TARH)常见且难治性比例高,导致的心、脑、肾、大血管等靶器官不良事件发生率高,严重影响TA患者的预后,是TA患者死亡的重要原因之一。目前尚无TARH诊治的指南或共识,为此,我们联合国内风湿免疫科、心内科、肾内科、血管外科、神经内科等相关学科专家在国内首次制定了中国TARH诊治多学科专家共识,旨在为相关临床科室提供治疗上的指导与建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国大动脉炎相关高血压诊治多学科专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9178a1c0022e894a, title=中国大动脉炎相关高血压诊治多学科专家共识, enTitle=, guiderFrom=复旦学报, authorId=0, author=, summary=目前尚无TARH诊治的指南或共识,为此,我们联合国内风湿免疫科、心内科、肾内科、血管外科、神经内科等相关学科专家在国内首次制定了中国TARH诊治多学科专家共识,旨在为相关临床科室提供治疗上的指导与建议, cover=https://img.medsci.cn/20211130/1638248735739_5579292.jpg, journalId=0, articlesId=null, associationId=2184, associationName=大动脉炎相关高血压诊治多学科共识中国专家组, associationIntro=大动脉炎相关高血压诊治多学科共识中国专家组, copyright=0, guiderPublishedTime=Tue Mar 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">大动脉炎(Takayasu&rsquo;s arteritis,TA)是好发于亚洲国家年轻女性的原发性血管炎症性疾病,大动脉炎相关高血压(Takayasu&rsquo;s arteritis-related hypertension,TARH)常见且难治性比例高,导致的心、脑、肾、大血管等靶器官不良事件发生率高,严重影响TA患者的预后,是TA患者死亡的重要原因之一。目前尚无TARH诊治的指南或共识,为此,我们联合国内风湿免疫科、心内科、肾内科、血管外科、神经内科等相关学科专家在国内首次制定了中国TARH诊治多学科专家共识,旨在为相关临床科室提供治疗上的指导与建议。</span></p>, tagList=[TagDto(tagId=383, tagName=大动脉炎)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=383, guiderKeyword=大动脉炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5219, appHits=198, showAppHits=0, pcHits=344, showPcHits=5021, likes=2, shares=21, comments=3, approvalStatus=1, publishedTime=Tue Nov 30 13:20:51 CST 2021, publishedTimeString=2021-03-30, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Nov 30 13:11:08 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 08:22:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国大动脉炎相关高血压诊治多学科专家共识.pdf)])
中国大动脉炎相关高血压诊治多学科专家共识.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2180837, encodeId=7867218083e91, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b7e2626091, createdName=tingtingff, createdTime=Thu Jan 11 20:26:12 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187892, encodeId=bc5b118e8926a, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:07:09 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084879, encodeId=bcbc10848e902, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 27 21:37:57 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2024-01-11 tingtingff 来自山东省

    很有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2180837, encodeId=7867218083e91, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b7e2626091, createdName=tingtingff, createdTime=Thu Jan 11 20:26:12 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187892, encodeId=bc5b118e8926a, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:07:09 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084879, encodeId=bcbc10848e902, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 27 21:37:57 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-01-25 502833265

    非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2180837, encodeId=7867218083e91, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b7e2626091, createdName=tingtingff, createdTime=Thu Jan 11 20:26:12 CST 2024, time=2024-01-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187892, encodeId=bc5b118e8926a, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e241530233, createdName=502833265, createdTime=Tue Jan 25 04:07:09 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084879, encodeId=bcbc10848e902, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 27 21:37:57 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 ms6000000225486324

    学习了

    0

拓展阅读

2021 ACR/VF指南:巨细胞动脉炎和大动脉炎的管理

美国风湿病学会(ACR,American College of Rheumatology) · 2021-07-08

大动脉炎全病程多学科慢病管理指南计划书

复旦大学附属中山医院 · 2023-07-20

2023 PANLAR指南:大动脉炎的治疗

泛美抗风湿联盟(PANLAR,Pan2American League Against Rheumatism) · 2023-08-10

中国大动脉炎全病程多学科慢病管理专家共识

复旦大学附属中山医院 · 2023-08-15